Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine

In Norway, the incidence of invasive meningococcal disease (IMD) is higher among 16–19-year-olds than in the general population. Most IMD cases among teenagers are caused by serogroup Y. Since 2011, one dose of meningococcal ACWY conjugate vaccine (MCV4) has been recommended for teenagers with out-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Watle, Sara Viksmoen, Næss, Lisbeth Meyer, Tunheim, Gro, Caugant, Dominique A., Wisløff, Torbjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475610/
https://www.ncbi.nlm.nih.gov/pubmed/33631080
http://dx.doi.org/10.1080/21645515.2021.1880209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475610/
https://www.ncbi.nlm.nih.gov/pubmed/33631080
http://dx.doi.org/10.1080/21645515.2021.1880209

Ejemplares similares